A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes.
Xin WangIris BroceYuqi QiuKacie D DetersChun Chieh FanAnders M DaleSteven D EdlandSarah J Banksnull nullPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Incorporating a PHS inclusion criterion represents a low-cost and accessible way to identify potential participants for AD clinical trials.
Keyphrases